Abstract:Atherosclerosis, a chronic inflammatory condition, is characterized by the accumulation of foam cells derived from macrophages that engulf oxidized low-density lipoprotein (oxLDL) via scavenger receptors and atherosclerosis-related protein receptors. Our initial investigation revealed that pristine graphene, lacking functional groups, exhibits a substantial binding affinity for both scavenger receptors (CD36, SRA1, LOX1) and atherosclerosis-related protein such as Toll-like receptor 4 (TLR4). This observation led us to postulate that graphene oxide (GO) and reduced graphene oxide (rGO), enriched with functional groups, may demonstrate even more robust binding capabilities. In the present study, our objective was to explore these binding interactions through molecular docking and molecular dynamics (MD) simulations involving graphene-based nanomaterials, including graphene, GO, and rGO, in relation to their interactions with atherosclerosis-related protein receptors. This allowed us to anticipate their potential influence on the formation of foam cells derived from macrophages. We employed AutodockVina for molecular docking analysis, assessing the ligands (graphene, GO, and rGO) and predicting the active binding sites on atherosclerosis-related protein receptors (LOX-1, SRA-1, TLR4, and CD36) with the assistance of P2Rank. Remarkably, the docking scores for graphene, GO, and rGO with all target proteins consistently fell below − 5 kcal/mol. Our exploration was further enriched by the application of the BINANA binding analyzer 2.2, which facilitated the visualization of intricate protein–ligand interactions. Additionally, the analysis of MD simulations using the CHARMM force field revealed significant conformational changes and binding energy within the protein–ligand complexes, notably occurring within the initial 100 ns (ns) of the simulations. These findings provide invaluable insights into the potential role of graphene-based nanomaterials in modulating the development of atherosclerosis.

Exploring the interaction of graphene-based nanomaterials with atherosclerosis-related protein targets: insights from molecular docking and dynamics simulations

Biological applications of graphene oxide

Adsorption Mechanism of Amyloid Fibrils to Graphene Nanosheets and Their Structural Destruction

Targeting and promoting atherosclerosis regression using hybrid membrane coated nanomaterials via alleviated inflammation and enhanced autophagy

Surface Inhomogeneity of Graphene Oxide Influences Dissociation of Aβ16-21 Peptide Assembly.

In silico bioactivity prediction of proteins interacting with graphene-based nanomaterials guides rational design of biosensor

The Role of Basic Residues in the Adsorption of Blood Proteins Onto the Graphene Surface

Computational exploration of Ganoderma lucidum metabolites as potential anti-atherosclerotic agents: Insights from molecular docking and dynamics simulations

Potential Interference of Graphene Nanosheets in Immune Response Via Disrupting the Recognition of HLA-presented KK10 by TCR: a Molecular Dynamics Simulation Study.

Selective regulation of macrophage lipid metabolism via nanomaterials' surface chemistry

Molecular Dynamics Simulations Reveal the Mechanism of Graphene Oxide Nanosheet Inhibition of Aβ1-42 Peptide Aggregation.

Reduction and simultaneous doping of graphene oxide to repel LDL in treatment of atherosclerosis disease

Interaction Behaviors of Fibrinopeptide-A and Graphene with Different Functional Groups: A Molecular Dynamics Simulation Approach

Insights into Mechanism of Aβ42 Fibril Growth on Surface of Graphene Oxides: Oxidative Degree Matters.

Studies of the interaction of graphene oxide (GO) with endothelial cells under static and flow conditions

Reduced Cytotoxicity of Graphene Nanosheets Mediated by Blood-Protein Coating.

Nanoscale graphene oxide (nGO) as artificial receptors: implications for biomolecular interactions and sensing.

Gelatin-decorated Graphene oxide: A nanocarrier for delivering pH-responsive drug for improving therapeutic efficacy against atherosclerotic plaque

Impact of Graphene Oxide on the Structure and Function of Important Multiple Blood Components by A Dose-Dependent Pattern

Insight into the Interaction of Graphene Oxide with Serum Proteins and the Impact of the Degree of Reduction and Concentration

On the biocompatibility of graphene oxide towards vascular smooth muscle cells